贝达药业
(300558)
| 流通市值：204.88亿 | | | 总市值：205.44亿 |
| 流通股本：4.22亿 | | | 总股本：4.23亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,975,927,792.57 | 1,039,835,367.29 | 3,609,338,576.55 | 2,717,342,723.91 |
| 营业总成本 | 1,650,821,748.41 | 777,633,137.59 | 3,158,280,259.83 | 2,301,749,460.62 |
| 其他经营收益 | | | | |
| 营业利润 | 369,118,999.25 | 282,894,437.9 | 418,382,880.55 | 394,491,937.66 |
| 利润总额 | 368,314,759.02 | 282,468,142.66 | 414,363,023.02 | 391,574,046.96 |
| 净利润 | 292,690,071.67 | 231,159,602.66 | 286,208,754.84 | 303,006,092.01 |
| 每股收益 | | | | |
| 其他综合收益 | -275,637,496.56 | -39,992,311.79 | 709,253,597.77 | 43,432,024.6 |
| 综合收益总额 | 17,052,575.11 | 191,167,290.87 | 995,462,352.61 | 346,438,116.61 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,741,542,151.82 | 1,670,487,798.3 | 1,577,826,705.15 | 1,484,177,061.95 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,557,849,618.6 | 9,017,785,129.33 | 8,987,819,882.54 | 8,215,285,574.75 |
| 资产总计 | 10,299,391,770.42 | 10,688,272,927.63 | 10,565,646,587.69 | 9,699,462,636.7 |
| 流动负债: | | | | |
| 流动负债合计 | 2,055,197,632.54 | 1,686,428,885.84 | 1,917,279,973.2 | 1,927,160,477.24 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,607,553,940.13 | 2,139,207,789.14 | 1,980,683,132.71 | 1,852,740,722.27 |
| 负债合计 | 3,662,751,572.67 | 3,825,636,674.98 | 3,897,963,105.91 | 3,779,901,199.51 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,625,836,980.33 | 6,794,857,192.49 | 6,595,157,402.93 | 5,843,399,746.13 |
| 股东权益合计 | 6,636,640,197.75 | 6,862,636,252.65 | 6,667,683,481.78 | 5,919,561,437.19 |
| 负债和股东权益合计 | 10,299,391,770.42 | 10,688,272,927.63 | 10,565,646,587.69 | 9,699,462,636.7 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,911,783,963.48 | 1,014,003,798.85 | 3,690,815,557.99 | 2,737,853,928.25 |
| 经营活动现金流出小计 | 1,499,444,259.4 | 750,396,110.05 | 2,779,554,649.76 | 2,069,423,681.33 |
| 经营活动产生的现金流量净额 | 412,339,704.08 | 263,607,688.8 | 911,260,908.23 | 668,430,246.92 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 175,949,689.26 | 40,051,689.8 | 1,074,286.07 | 1,013,509.42 |
| 投资活动现金流出小计 | 425,923,977.22 | 391,944,820.43 | 928,939,783.05 | 731,485,187.19 |
| 投资活动产生的现金流量净额 | -249,974,287.96 | -351,893,130.63 | -927,865,496.98 | -730,471,677.77 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 617,037,296.9 | 610,000,000 | 1,009,946,278 | 809,946,278 |
| 筹资活动现金流出小计 | 753,027,039.61 | 530,185,009.2 | 1,036,121,987.43 | 807,159,708.6 |
| 筹资活动产生的现金流量净额 | -135,989,742.71 | 79,814,990.8 | -26,175,709.43 | 2,786,569.4 |
| 汇率变动对现金及现金等价物的影响 | -1,170,329.93 | -504,046.51 | 1,078,742.47 | 1,901,864.44 |
| 现金及现金等价物净增加额 | 25,205,343.48 | -8,974,497.54 | -41,701,555.71 | -57,352,997.01 |
| 期末现金及现金等价物余额 | 455,186,642.89 | 421,006,801.87 | 429,981,299.41 | 414,329,858.11 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 25,205,343.48 | - | -41,701,555.71 | - |
最新报告期：2026-08-22| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国金证券 | 甘坛焕 | 1.37 | 1.87 | 2.37 | 2026-08-22 |
| 东海证券 | 杜永宏 | 1.39 | 1.76 | 2.15 | 2026-08-12 |